SCHEMBL4906732

SCHEMBL4906732

CCN(c1ccc(OCc2cc(F)cc(F)c2)cc1)S(=O)(=O)c1cc(C)c(C)c(C(=O)O)c1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.47
MMP9 P14780 2/20 0.41
ADAM17 P78536 2/20 0.41
MMP2 P08253 1/20 0.41
MMP14 P50281 1/20 0.41
KMT2A Q03164 2/20 0.41
HSD17B10 Q99714 2/20 0.40
ESR1 P03372 2/20 0.40
MAOB P27338 1/20 0.40
ALDH1A1 P00352 1/20 0.40
HPGD P15428 1/20 0.40
ALOX15 P16050 1/20 0.40
TSHR P16473 3/20 0.40
KEAP1 Q14145 3/20 0.40
NFE2L2 Q16236 3/20 0.40
MMP13 P45452 1/20 0.39
MAPK1 P28482 2/20 0.39
GSK3B P49841 2/20 0.38
BACE1 P56817 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4897627 0.92 KEAP1 (0.48) LMNAMMP9ADAM17MMP2KMT2A
SCHEMBL4908025 0.91 MMP9 (0.42) LMNAMMP9ADAM17MMP2MMP14
SCHEMBL4904188 0.89 LMNA (0.53) LMNAMMP9ADAM17MMP2MMP14
SCHEMBL4906496 0.89 LMNA (0.51) LMNAMMP9ADAM17KMT2AHSD17B10
SCHEMBL4897727 0.86 MMP2 (0.48) LMNAMMP9MMP2MAOBKEAP1
SCHEMBL4906071 0.85 LMNA (0.53) LMNAMMP9ADAM17MMP2MMP14
SCHEMBL4906264 0.85 LMNA (0.52) LMNAKMT2AHSD17B10ESR1ALDH1A1
SCHEMBL4907012 0.83 LMNA (0.49) LMNAKMT2AHSD17B10ESR1ALDH1A1
SCHEMBL4904039 0.83 KEAP1 (0.47) LMNAMMP9ADAM17MMP2MMP14
SCHEMBL4894515 0.83 LMNA (0.45) LMNAMMP9ADAM17KMT2AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD LMNA 319/4885MMP9 4632/4885ADAM17 4813/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD LMNA 319/4885MMP9 4632/4885ADAM17 4813/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.